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Transient Left Ventricular Apical
Ballooning and Outflow Tract Obstruction
In the interesting syndrome of transient left ventricular apical
ballooning (TLVAB) without coronary artery stenosis mimicking
acute myocardial infarction, originally described by Tsuchihashi et
al. (1), clinical manifestations in most patients were preceded by
severe physical or emotional stress, suggesting a catecholamine-
mediated mechanism. In a recent issue of the Journal, Abe et al. (2)
described the clinical characteristics of a new series of 17 patients
with TLVAB and disscuss and investigate different possible
pathogenic mechanisms for this syndrome. The investigators could
not identify any specific cause, suggesting neurogenic myocardial
stunning induced by emotional or physical stress as the most
probable etiology. Surprisingly, the previously suggested (1) pos-
sible role of a transient dynamic left ventricular outflow tract
(LVOT) obstruction in the pathogenesis of this syndrome was not
investigated by these researchers, who did not even mention the
possible existence of such gradients in their patients. However, we
believe there is much evidence indicating that this relation actually
exist. In fact, a transient dynamic LVOT gradient was detected at
initial evaluation in a substantial proportion of the patients
described by Tsuchihashi et al. (1), and in other cases of this
syndrome described elsewhere (3,4). In these patients, the clinical
and hemodynamic situation improved as the gradient disappeared.
Moreover, in some of the patients presenting with cardiogenic
shock, this situation persisted until the dynamic obstruction was
diagnosed and specifically treated (3).
Thus, at least in some patients, a possible mechanism for
TLVAB could be a dynamic LVOT obstruction preceding the
ischemic event. Once present, the dynamic obstruction elevates left
ventricular filling pressures, increasing myocardial oxygen demand
at the mid-to-apical cavity. If this situation persists, apical hypo-
perfusion and ischemia may result, with eventual apical infarc-
tion. In fact, it is well known that, even in normal hearts,
exposure to an exogenous catecholamine, such as dobutamine
infusion, can precipitate dynamic LVOT obstruction (5). Some
patients, primarily women, may have geometric predisposition
(sigmoid interventricular septum, small LVOT, reduced left
ventricular volume) to dynamic LVOT obstruction, which may
manifest only in the setting of intense adrenergic stimulation or
hypovolemia (3,5). In these susceptible patients, increased
adrenergic tone might produce primary LVOT obstruction
leading to secondary ischemia and focal wall-motion abnormal-
ities. Thus, the intense physical or emotional stress that
precedes apical ischemia in most patients with TLVAB could be
the trigger for the acute development of LVOT obstruction
capable of producing severe apical ischemia.
Identification of acute dynamic LVOT obstruction as the
possible initial mechanism in some of these patients may have
important clinical and therapeutic implications, as the use of
traditional measures to treat patients with chest pain and
evidence of myocardial ischemia, including nitrates and after-
load reduction, would actually increase the LVOT gradient,
causing further clinical deterioration, while abolishing the
gradient (with beta-blockers, intravenous fluids, or alpha-
adrenergic receptor stimulation) might be beneficial and even
life-saving (3). Moreover, treatment for secondary prevention
would depend also on the suspected underlying mechanism.
Eventually, in those patients in whom an acute dynamic LVOT
obstruction mechanism is suspected, the possibility of perform-
ing tests of provocation, such as dobutamine stress echocardi-
ography, should be considered.
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REPLY
We appreciate the comments and acknowledge the concerns of Dr.
Penas-Lado and colleagues regarding the etiology of transient left
ventricular apical ballooning described in our report (1). It may be
quite reasonably argued that transient dynamic left ventricular
outflow tract obstruction contributes to the pathogenesis of this
syndrome (2). Tsuchihashi et al. (3) speculated on the inclusion of
stress cardiomyopathy caused by vigorous stress (catecholamine
exposure), dynamic midventricular obstruction due to basal hyper-
contraction, and/or secondary myocardial ischemia (increased wall
tension) as an important etiological cause of this syndrome.
However, they reported that only 18% of patients (12/72 patients)
had left ventricular outflow tract obstruction and an intraventric-
ular pressure gradient 30 mm Hg during the acute phase.
We did not discuss findings of left ventricular outflow tract
obstruction in our report (1) for the following reasons. No patient
showed left ventricular outflow tract obstruction with an intraven-
tricular pressure gradient 30 mm Hg among 9 patients who
underwent pressure recording during catheter withdrawal from the
left ventricle and/or an accelerated flow in the left ventricular
outflow tract in any of the 17 patients who underwent Doppler
echocardiography during the acute phase. Moreover, little evidence
was seen of geometric predisposition (sigmoid intraventricular
septum, small left ventricular outflow tract, abnormal orientation
of a slack mitral apparatus, reduced left ventricular volume) in our
patients. However, pathological findings of the specimen obtained
from left ventricular endomyocardial biopsy during the acute phase
differed from those of myocardial ischemia (1,3,4). Moreover,
Tawarahara et al. (5) recently reported a variant type of reversible
severe left ventricular wall-motion abnormality of the basal seg-
ment with hypercontraction at the apex. It was considered that left
ventricular outflow obstruction did not contribute to the etiology
of this type of transient left ventricular abnormality. Thus, these
findings suggested that left ventricular outflow obstruction was not
a primary cause of this syndrome.
Kono et al. (6) reported that the mechanism of neurogenic
stunned myocardium in patients with subarachnoid hemorrhage
was mediated by the direct toxic effect of norepinephrine. Mann et
al. (7) demonstrated the mechanism of catecholamine-mediated
cardiac toxicity was that adrenergic stimulation leads to cyclic
AMP-mediated calcium overload of cultures of adult cardiac
muscle cells exposed to norepinephrine. Doshi et al. (8) reported
that individual necrotic muscle fibers surrounded by macrophages
and inflammatory cells and small foci of inflammatory cells
between the muscle fibers with or without the presence of necrotic
muscle fibers were observed histologically in patients with sub-
arachnoid hemorrhage. These reports suggest that the direct
toxicity of catecholamines could lead to myocyte damage.
Because none of our patients demonstrated neither significant
left ventricular outflow tract obstruction nor intraventricular pres-
sure gradient nor the evidence of geometric predisposition in our
study, left ventricular outflow obstruction was not considered a
primary cause. Therefore, we considered that this syndrome might
be caused by the direct toxicity of catecholamines.
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Are Levels of C-Reactive Protein and
Troponin T the Best Predictors of
Mortality After Acute Coronary Syndrome?
We read with great interest the article by James et al. (1) in a recent
issue of the Journal.
We were puzzled by the finding that C-reactive protein (CRP)
was related to 30-day mortality, but not to the occurrence of
myocardial infarction (MI). Indeed, as shown by Table 3, not only
was CRP unrelated to MI, but patients with a CRP value 1.84
mg/l had a paradoxically lower probability of MI than did patients
with values 1.84 mg/l (odds ratio 0.76, 95% confidence interval
0.59 to 0.98, p  0.03). We believe that these findings can be
explained by considering the potential relation (not addressed in
the report) between high CRP values and impaired left ventricular
(LV) function. Indeed, patients in the fourth CRP quartile had a
higher rate of presentation with heart failure than did patients
included in the other quartiles (p 0.001). Moreover, as shown in
Table 2 of the study, a strict relation existed between median
troponin T values and CRP (0.04, 0.08, 0.1, and 0.3 g/l being,
respectively, the troponin T values in the four CRP quartiles, p 
0.001). It is likely that high CRP values would reflect large infarcts
with impairment of LV function, an important predictor of early
death, not necessarily related to the occurrence of a subsequent MI.
Unfortunately, the investigators (1) did not include in the
multivariable analysis any index of LV function; therefore, the
independent prognostic predictivity of CRP remains questionable.
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